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Abstract
Background: The aim of this study was a) To identify predictors of the use of aspirin in the pre-hospital setting in
acute myocardial infarction (AMI) and b) To analyze whether the use of any of the recommended medications was
associated with outcome.
Methods: All patients with a final diagnosis of AMI, transported by the Emergency Medical Services (EMS) and
admitted to the coronary care unit at Sahlgrenska University Hospital in Gothenburg, Sweden, in 2009–2011,
were included.
Results: 1,726 patients were included. 58 % received aspirin by the EMS. Ischemic heart disease (IHD) was suspected in
84 %. Among patients who did not receive aspirin IHD was still suspected in 67 %. Among patients in whom IHD was
suspected, and who were not on chronic treatment with aspirin the following predicted its pre-hospital use: a) age
(odds ratio 0.98; 95 % confidence interval (CI) 0.96–0.99); b) a history of myocardial infarction (2.21; 1.21–4.04); c) priority
given by EMS (8.07; 5.42–12.02); d) ST-elevation on ECG on admission to hospital (2.22; 1.50–3.29); e) oxygen
saturation > 90 % (3.37; 1.81–6.27).
After adjusting for confounders among patients who were not on chronic aspirin, only nitroglycerin of the
recommended medications was associated with a reduced risk of death within 1 year (hazard ratio 0.40;
95 % CI 0.23–0.70).
Conclusions: Less than six out of ten patients with AMI received pre-hospital aspirin. Five clinical factors were
independently associated with the pre-hospital administration of aspirin. This suggests that the decision to
treat is multifactorial, and it highlights the lack of accurate diagnostic tools in the pre-hospital environment.
Nitroglycerin was independently associated with a reduced risk of death, suggesting that we select the use
for a low-risk cohort.
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Background
With the exception of fibrinolysis [1], the evidence for
the use of medication before hospital admission in sus-
pected acute myocardial infarction (AMI) is limited [2].
Despite this fact, pre-hospital pharmacological interven-
tion has been routine in most developed countries for at
least 25 years. The drugs recommended by guidelines
have remained largely unchanged and include oxygen,
aspirin, nitroglycerin and morphine. In addition, other
drugs, such as clopidogrel and beta-blockers, have been
introduced as pre-hospital treatment but then often on a
more strict indication.
Most studies of pharmacological interventions in AMI
have been performed in hospital settings. Even though in-
terventions with oxygen, nitroglycerin, aspirin and mor-
phine have been widely accepted and used for a long time,
the scientific evidence of their benefit is limited and in
some cases contradictory. A Cochrane report concluded
that the underlying evidence for the widespread use of
oxygen in AMI is suggestive of possible harm [3]. The use
of morphine in AMI has been shown to relieve pain [4, 5],
but it has not been shown to improve outcome. On the
contrary, in cases of unstable angina pectoris and non-ST-
elevation myocardial infarction, morphine has been asso-
ciated with an increased mortality rate [6].
Nitroglycerin has been extensively studied in acute
coronary syndrome (ACS). The ISIS-4 and GISSI-3 trials
convincingly demonstrated that the continued treatment
with nitroglycerin after a coronary event had no prog-
nostic benefit [7, 8]. On the other hand, a recent
Cochrane report concluded that, if used within the first
24 h, nitroglycerin is associated with a reduced risk of
death within the first two days [9]. This suggests that
nitroglycerin is of the greatest benefit early in the treat-
ment of AMI. The risks and potential benefit of very
early treatment with nitroglycerin in the pre-hospital set-
ting have, however, only been sparsely studied. To our
knowledge, no randomized, controlled trial has been
conducted on the subject. In observational studies, the
pre-hospital administration of sublingual nitroglycerin is
reported to be safe, with the predominant adverse effect
being hypotension (with an incidence of 0.7–3.2 %)
[10, 11], and to be associated with reduced chest pain [10].
Aspirin has been shown to have a positive effect on
outcome in AMI. In 1988, the ISIS-2 incontrovertibly
established aspirin as an integral part of the treatment in
AMI [12]. Although ISIS-2 did not clearly document
that very early treatment is better than later administra-
tion of aspirin (e.g. within the first 24 h), it soon became
routine in many countries, including Sweden, to admin-
ister aspirin pre-hospitally. The current guidelines state
that an oral loading dose of 300 mg should be given as
early as possible by the EMS on suspicion of ACS [13].
The pre-hospital administration of aspirin has been
reported to be safe [14], but the true benefit of this strat-
egy has never been documented. Observational studies
comparing the outcome among patients who received
very early aspirin with those who received it later on
have produced conflicting results [15–18]. Furthermore,
the adherence of EMS clinicians to the recommenda-
tions has been reported to vary, with pre-hospital aspirin
being administered to ideal candidates in 33–62 % of all
cases [19–22]. One small study exploring the reasons for
this relatively low adherence concluded that the leading
reason for the EMS provider not to administer aspirin
was that the chest pain was not believed to be of cardiac
nature [21].
Aspirin has proven benefits, with a tendency towards
greater benefit with very early treatment [12]. This pos-
sibly makes it the most important intervention in the
pre-hospital setting. We therefore aimed to identify pre-
dictors of the use of aspirin in the pre-hospital setting in
AMI and to analyze whether the use of any of the rec-
ommended medications was associated with outcome. A
secondary objective was to assess predictors for a suspi-




The county of Västra Götaland is the second largest
county in Sweden, with approximately 1.6 million people
in an area of 24,000 km2. Sahlgrenska University Hos-
pital in Gothenburg (600,000 inhabitants) is one of four
percutaneous coronary intervention (PCI) centers in the
county.
In Sweden, 112 is the common public emergency
phone number for all emergency services. At the time of
the study, all calls to the dispatch center on medical
issues were redirected to a nurse, whom through a sys-
temized caller-interrogation, using decision support soft-
ware, determined a response output category for the
case: (1) Immediately life threatening; (2) Urgent, but
not life threatening; (3) A reasonable waiting time is not
considered to influence the patients condition.
The ambulances were staffed by one nurse clinician,
responsible for the pre-hospital triage and care, and one
emergency medical technician. The educational level of
nurse clinicians in the EMS was three years university
studies to achieve a degree of Bachelor in nursing, and
one additional year to achieve a degree of Master in pre-
hospital nursing. A pre-hospital triage protocol (METTS-
Pre) and local EMS guidelines were used as decision
support. All the ambulances were equipped with a moni-
tor/defibrillator. The pre-hospital ECGs were assessed
manually. If ECG abnormalities were detected, the ECG
was sent, using telemedicine, to the corresponding coron-
ary care unit (CCU) for evaluation by a nurse at the CCU
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and, if necessary, with the support of an on-call cardiolo-
gist. If ST-elevation or a left bundle branch block (LBBB)
were present, the patient was transported to the CCU
or directly to the catheterization laboratory, bypassing
the emergency department (ED). If not, the patient
was transported to the nearest ED. After assessment
by an ED physician, a large proportion was subse-
quently transferred to the CCU on suspicion of AMI
(and thus included in this study).
The decision to administer oxygen, sublingual ni-
trates, intravenous morphine and oral aspirin was at
the discretion of the nurse clinician. The standard
dose of aspirin was 300 mg. After telephone contact
with the receiving cardiologist, intravenous beta-
blockade (rarely) and/or oral clopidogrel could also be
administered pre-hospitally.
Population and data collection
This study comprised consecutive patients admitted to
the CCU at Sahlgrenska University Hospital between 1
January 2009 and 31 December 2011, with a final diag-
nosis of AMI (ICD-10: I21-I22) at discharge. Thus, all
types of AMI were included in the analyses. All the pa-
tients had been transported to hospital by the EMS. Data
were obtained from the Register of Information and
Knowledge about Swedish Heart Intensive care Admis-
sions (RIKS-HIA). The list consisted of 2,524 events.
The matching EMS casebook was identified in the med-
ical log program used by EMS in the county of Västra
Götaland; AmbuLink. In total 798 cases were excluded
before analysis. The reasons for exclusion were: a) the
transport was made by EMS from another county or the
relevant EMS casebook was missing (n = 280), b) the
transport was from a referral hospital, where diagnosis
and initial treatment already had been given (any prior
transport to the ED at the referral hospital was however
included) (n = 164), c) the transport was from a local
health center, where treatment already had been initiated
(n = 252), d) cases involving a cardiac arrest, drastically
altering treatment strategy (n = 97) and e) missing infor-
mation on pre-hospital aspirin (n = 5).
In the excluded cases it was not regarded as meaning-
ful to evaluate the use of aspirin since such treatment
had already been started by others.
Statistical methods
Data are presented as crude (i.e. not age-adjusted) rates.
All p-values in Tables 1 and 2 and Additional file 1:
Tables S1 and S2, except for age itself, are age adjusted.
Age was compared using the Mann–Whitney U-test.
Logistic regression was used to calculate age-adjusted
p-values for difference in proportions. To identify
predictors of the pre-hospital use of aspirin among
patients with suspected IHD and not on previous
chronic aspirin, multiple logistic regression was used,
in a forward stepwise selection mode, with p < 0.01 as
a criterion for staying in the model. Variables tested
for inclusion in the model were those relevant baseline
factors with a univariate p-value below 0.05 for association
with pre-hospital aspirin in this group of patients. The
same strategy was used to identify predictors of IHD
assessment in all patients. See Additional file 1 for a
complete list of variables tested.
For mortality analyses, Kaplan-Meier estimates were
used and age-adjusted p-values and hazard ratios with
corresponding confidence intervals were calculated
using Cox’s proportional hazards model. The associ-
ation between the six recommended medications and
one-year mortality among patients with no previous
aspirin was analyzed for each medication separately









Oxygen 78 88 62 <0.0001
Nitroglycerine 66 82 45 <0.0001
Aspirin 58 100 0 ———
Morphine 57 76 30 <0.0001
Beta-blockers 2 2 1
Clopidogrel 38 64 3 <0.0001
*Age adjusted p-value, denoted if <0.05










Age (mean ± SD) 70 ± 13 68 ± 13 73 ± 13 <0.0001
Women 33 29 39 0.03
Previous history
Diabetes (7)a 20 18 23 0.01
Hypertension (21)a 44 42 47
Smoking (98)a 27 30 24
Myocardial infarction (19)a 28 22 36 <0.0001
Heart failure (72)a 9 5 13 <0.0001
PCI (25)a 16 13 19 0.0008
Heart surgery (14)a 9 7 12 0.001
Stroke (19)a 10 7 14 <0.0001
Medication
Aspirin (27)a 38 31 46 <0.0001
Any other cardiovascular
drug (51)a
61 54 71 <0.0001
*Age adjusted p-value (except for age itself), denoted if <0.05
aNumber of patients with missing information
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and adjusted for all baseline and in-hospital treatment
variables with a univariate p < 0.10 for association
with mortality (see Additional file 1). All the tests
were two sided and p-values below 0.01 were consid-
ered statistically significant. All the analyses were per-
formed using SAS for Windows version 9.3.
Ethical considerations
This study has been conducted within the framework
of a master’s thesis at Sahlgrenska University Hospital
and is therefore not subjected to review by the Swed-
ish Ethical Reviewer Boards. However, the work was
done according to the Swedish law (SFS) 2003:460;
the law of ethical considerations and human trials,
and according to the Helsinki Declaration. In all the
analyses, patients remained anonymous and patient
integrity was thus respected. Patients included in
RIKS-HIA have been given information about partici-
pation in the register and have been given the oppor-
tunity to decline.
Results
Medication administered by EMS
In all, 1,726 patients were transported by the EMS to
hospital and fulfilled the criteria for AMI. Table 1 shows
the use of various medications. Pre-hospital aspirin was
administered in 58 % of the cases. The administration of
oxygen, nitroglycerin, morphine and clopidogrel was
more common in the group receiving aspirin.
Age, gender and previous history
The overall mean age was 70 years, and 33 % were
women. Patients that received aspirin were younger than
those that did not, and had fewer indications of previous
cardiovascular disease, as shown in both their previous
history and their previous chronic medication (Table 2).
Symptoms and initial assessment by dispatchers and EMS
In 92 % of all cases a pre-hospital ECG was recorded
and the nurse clinician suspected IHD as the under-
lying etiology in 84 % of all cases. Among patients
who received aspirin there was an initial suspicion of
IHD in 96 %, whereas among patients who did not
receive aspirin a suspicion of IHD was raised in only
67 % (p < 0.0001). When comparing patients who re-
ceived aspirin with those who did not there were
many differences in terms of symptoms, initial assess-
ment and hemodynamics. In summary, patients who
received aspirin differed from those who did not in
that they were given a higher priority by the dis-
patchers and by the EMS; chest pain and pain in the
arms were more prevalent; they more often had cold
sweat and nausea; and they had less tachycardia and
less oxygen desaturation. For details see Additional
file 1: Table S1.
Status on admission to hospital, treatment and
investigation in hospital and 1 year mortality
Fifty-eight percent of the patients had ST-elevation on
first in-hospital ECG. ST-elevation was more common
among the patients that had received pre-hospital as-
pirin. When comparing patients who received aspirin
with those who did not there were differences in the
use of various medications after hospital admission.
Investigations such as coronary angiography and
echocardiography were performed more frequently
among those who received aspirin. For more details
see Additional file 1: Table S2.
The overall one-year mortality was 13.6 %. Patients
who were given aspirin pre-hospitally had a lower one-
year mortality than those who did not (10.1 % versus
18.6 %; p = 0.009).
Predictors of the administration of aspirin by EMS
In this analysis we only included patients in whom there
was a suspicion of IHD and excluded patients on
chronic medication with aspirin. Five independent pre-
dictors of the use of aspirin were identified, as shown in
Table 3.
Pre-hospital pharmacological intervention in relation to
one-year mortality
When adjusted for all potential confounders recorded,
the only drug associated with a reduced risk of death
within one year of follow-up was nitroglycerin (Table 4).
Predictors of assessment as ischemic heart disease
There were seven predictors for such an assessment by
the EMS clinician (Table 5).
Table 3 Predictors of the use of aspirin prior to hospital
admission among patients with suspected IHD and not on
previous chronic aspirin medication
ORa (95 % CI)a p
Age (per year) 0.977 (0.963, 0.991) 0.001
Previous history
Myocardial infarction 2.21 (1.21, 4.04) 0.01
EMS assessment
Priority 8.07 (5.42, 12.02) <0.0001
ECG pattern
ST-elevation 2.22 (1.50, 3.29) <0.0001
Cardio-respiratory finding
Oxygen saturation ≥90 % 3.37 (1.81, 6.27) 0.0001
aOdds ratio (95 % confidence interval)
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Discussion
The three major results from this study are as follows:
a) Fifty-eight percent of the patients with a final
diagnosis of AMI transported by the EMS in the
Municipality of Gothenburg received aspirin by
EMS before hospital arrival.
b) A variety of clinical factors were associated with the
pre-hospital use of aspirin by EMS. They reflect the
patients’ age, previous history, the initial assessment
made by the EMS clinicians, the initial ECG pattern
and the patients’ cardiorespiratory status (oxygen
saturation).
c) The pre-hospital use of nitroglycerin, when adjusted
for confounders, was associated with a reduced risk
of death during one year of follow-up.
Use of aspirin
In previous reports from Sweden and other countries,
the proportion of patients with suspected AMI treated
with aspirin pre-hospitally varies between 33 % and 62 %
[15, 19–22] and the 58 % in the present study is thus in
line with previous findings. There are several possible
explanations as to why adherence to guidelines was so
low. In an earlier study, the main reason for EMS pro-
viders not to administer aspirin was that the chest pain
was not believed to be of cardiac nature [21]. In the
present study the nurse clinician stated IHD as the sus-
pected etiology in 84 % of all cases, indicating that in
some cases the nurse clinician failed to identify the con-
dition as an ACS. In these cases, the decision not to
treat is the logical consequence of the assessment. How-
ever, among the patients not receiving aspirin the nurse
clinician still suspected IHD in 67 % of the cases. The
reasons for withholding treatment in these cases are not
apparent. One might be that a contraindication was
present, although the only contraindication stated in
local EMS guidelines at the time was known allergy to
acetylsalicylic acid. Emesis might be a more common
issue hindering the administration of aspirin (in Sweden,
aspirin is only available in oral dosage forms). Another
practical issue to consider is the time available for inter-
ventions. In an urban setting, the hospital is sometimes
only minutes away and the nurse clinician might have to
prioritize other actions.
Recent self-administration of aspirin was the second
most prevalent reason EMS providers gave for not
administering aspirin, in the previous study [21]. In this
study 38 % of the patients were prescribed aspirin for
regular use prior to the event. This might have influ-
enced the nurse clinicians decision, even though guide-
lines did not state that the loading-dose of aspirin
should be withheld from these patients.
Predictors of the use of aspirin
A history of myocardial infarction, and an initial suspi-
cion by the EMS clinician that IHD was the underlying
etiology, was associated with a higher use of aspirin, in-
dicating adherence to guidelines. High priority given by
the EMS clinician was a strong predictor of the use of
aspirin. In Gothenburg at the time, all pre-hospital ECGs
with an ST-elevation or a LBBB (but also other abnor-
malities) were sent to the CCU at Sahlgrenska University
Hospital. A nurse and/or an on-call cardiologist decided
whether the patient was to be accepted for direct trans-
port to the cardiac catheterization laboratory, the CCU,
or referred to the nearest ED. The patients accepted for
direct transport were often given high priority and this
was in turn a strong predictor of aspirin treatment.
On the other hand, patients referred to the nearest ED
received lower priority and therefore most probably had
a longer mean transportation time as a group. This
should have given the nurse clinician more time to ad-
minister treatment, but this group was instead less likely
to receive aspirin. This clearly reflects the possibility that
Table 4 Prehospital pharmacological intervention in relation to
1 year mortality among those not on previous chronic aspirin
medication (n = 1061) – each intervention analyzed separately
HRa (95 % CI)a p
Adjusted for confounders# from Tables 2, 3 and 4
Oxygen 0.97 (0.48, 1.95) 0.92
Nitroglycerine 0.40 (0.23, 0.70) 0.001
Aspirin 1.14 (0.60, 2.16) 0.69
Morphine 1.13 (0.62, 2.06) 0.69
Beta-blockers 1.45 (0.18, 11.76) 0.73
Clopidogrel 1.06 (0.56, 1.99) 0.86
aHazard ratio (95 % confidence interval)
#All factors with age adjusted p < 0.10 for association with 1 year mortality
Table 5 Predictors of assessment as ischemic heart disease
ORa (95 % CI)a p
Symptoms
Chest pain 15.67 (10.27, 23.90) <0.0001
Pain in arms 2.45 (1.58, 3.80) <0.0001
Cold sweat 1.75 (1.15, 2.65) 0.009
Dispatch center assessment
Priority 1.70 (1.20, 2.41) 0.003
ECG pattern
ST-elevation 2.67 (1.83, 3.89) <0.0001
No pathologic T-wave 2.95 (1.47, 5.91) 0.002
Cardio-respiratory finding
Oxygen saturation ≥90 % 2.16 (1.36, 3.42) 0.001
aOdds ratio (95 % confidence interval)
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a referral to the nearest ED was interpreted by the nurse
clinician as an “acquittal”, and that further interventions
were therefore unnecessary. If this is indeed a prevalent
interpretation, it reflects the importance of continuing
education. In the future, the CCU nurse or the on-call
cardiologist might also give advice about early treatment
in this subset.
The observation that a ST-elevation on the hospital
admission ECG, also predicted a higher use of aspirin is
in agreement with previous statements. In these cases,
the ambulance was redirected to the catheterization
laboratory or to the CCU, and the on-call cardiologist
often prescribed oral clopidogrel to be administered pre-
hospitally, in addition to standard treatment, making the
decision not to administer aspirin at the same time
controversial.
Oxygen saturation of ≥ 90 % predicted an increase in
the use of aspirin. This is most probably explained by a
more stable clinical condition in these patients. Patients
with low oxygen saturation are often in a bad clinical
condition creating problems with oral medication.
A lower age was associated with the use of aspirin sug-
gesting that age itself is a predictor of adherence to
guidelines.
The finding that patients who received aspirin in the
pre-hospital setting were more often revascularized is
most likely an independent finding, simply reflecting the
high incidence of ST-elevation AMI among these
patients.
The proportion of patients treated with coronary
artery bypass grafting was very low and in agreement
with previous findings [23].
Predictors of death
The use of nitrates was associated with a reduced risk of
death after adjustment for confounders. Nitrates have
been widely used in ACS for many years, are well tolerated
[10, 11] and are associated with a reduction in chest pain
in the pre-hospital setting [10]. To our knowledge, no ran-
domized placebo-controlled pre-hospital trial, investigat-
ing the effects of nitrates, has been performed. Two large,
randomized, placebo-controlled trials with randomization
after hospitalization have not shown any benefit in terms
of outcome [7, 8]. One explanation of our findings is that
there are confounders that were not adjusted for. It is
likely that patients with severe pain, often those with ST-
elevation, and without hemodynamic complications, were
more frequently given nitroglycerin. These patients are
reported to have a good outcome [24]. However, we
adjusted for ECG findings and for hemodynamic compli-
cations. Another, perhaps less likely, explanation is that
nitroglycerin, when given in the very early phase of acute
myocardial ischemia, has a beneficial effect on the myo-
cardium. A recent Cochrane report that included 18 trials
of nitrates in patients with an acute cardiovascular event
concluded that nitrates are associated with increased sur-
vival if administered within the first 24 h [9].
Predictors of assessment as ischemic heart disease
IHD was suspected in 84 % of all cases. The predictors of
such a suspicion included typical symptoms, a high priority
by the dispatcher, typical ECG signs and a normal oxygen
saturation. These findings suggest that the EMS clinicians,
to a great extent, had the knowledge and the ability to de-
tect AMI in patients with classical symptoms and signs.
However, far from all cases of AMI presents itself with this
symptom complex. Our findings suggest that the EMS cli-
nicians’ ability to detect AMI in patients with atypical
symptoms is limited. Today, pre-hospital decision-making
is based on clinical history and clinical findings. However,
recent data suggest that the use of biochemical markers in
the pre-hospital setting might help to further improve the
diagnostic accuracy [25].
Limitations
This is an observational, retrospective study. The study
was performed in an urban area with relatively short
transport times. The results might have been different,
had the study been undertaken in a rural area, even
though patients transported from other areas of the
county were frequent and not excluded.
The patients were recruited from the RIKS-HIA regis-
ter. At the time this register covered about ninety per-
cent of all patients hospitalized with AMI under the age
of 80 years. Older patients with severe co-morbidity are
not always admitted to the CCU and are therefore not
included in the register [23]. This, in combination with
the fact that this study only included patients trans-
ported with the EMS, may explain the high figure of ST-
elevation (58 %). In turn, this might explain why the
overall one-year mortality was relatively low (14 %).
We assume that the total number of patients admitted
to Sahlgrenska University Hospital, and having a final
diagnosis of AMI, was about 4000 during the inclusion
period. This figure is based on previous surveys [23].
The relatively large proportion of patients with ST-
elevation in our survey suggests that the pre-hospital
aspirin-use might have been even lower, had all patients
with AMI been included.
Two clinical parameters (ECG findings and signs of
heart failure) were recorded on admission to hospital in-
stead of pre-hospitally, due to difficulties retrieving this
information from the EMS chart. If information about
the pre-hospital ECG had been available, it is possible
that the proportion of patients with a pathological
finding would have been different, as both time, and
pre-hospital medication might have influenced the
ECG pattern.
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Patients who had taken aspirin (typically 75 mg) before
EMS arrival constitute a confounding factor, when relat-
ing aspirin use to outcome. These patients were analyzed
as though they did not receive aspirin and were there-
fore not included in the multivariate analyses.
Conclusion
Less than six out of ten patients with AMI received pre-
hospital aspirin. Five clinical factors were independently
associated with the pre-hospital administration of as-
pirin. This suggests that the decision to treat is multifac-
torial, and it highlights the lack of accurate diagnostic
tools in the pre-hospital environment.
Nitroglycerin was independently associated with a
reduced risk of death, suggesting that we select the use
for a low-risk cohort.
Clinical implications
The lack of scientific evidence for the use of various
medications prior to hospital admission is a clinical
dilemma. Is the current strategy of administering several
oral and intravenous drugs pre-hospitally, thereby pos-
sibly delaying transport, of the greatest benefit to the
patient? This needs to be evaluated in future research.
Less than six out of ten patients with an AMI received
aspirin by the EMS. Since the lack of suspicion of IHD
and low priority were linked to a lower use of aspirin,
we need better instruments to detect AMI in the early
phase. We also need clarified EMS guidelines regarding
aspirin administration to patients already on chronic
treatment.
Furthermore, our data suggest that we select the use
of nitroglycerin for a low-risk cohort. Any possible bene-
ficial effect of nitroglycerin needs to be highlighted in a
randomized trial.
Additional file
Additional file 1: List of baseline variables and additional tables.
Baseline variables tested for inclusion in the model identifying predictors
of the use of aspirin, prior to hospital admission, in patients with no
previous chronic aspirin medication and with a suspicion of IHD. Baseline
variables tested for inclusion in the model identifying predictors of
assessment as ischemic heart disease, in all patients. Baseline and in-
hospital treatment variables used for adjustment when analyzing
association between each of the six recommended pre-hospital
medications and one-year mortality, in patients with no previous chronic
aspirin medication. Table S1, displaying symptoms and initial assessment
by dispatchers and EMS. Table S2, displaying status on admission to
hospital, treatment and investigation in hospital, 30 days and 1 year
mortality. (DOC 35 kb)
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